Search

Home > GRACEcast > Dr. Greg Riely: How Should We Approach Acquired Resistance to Targeted Therapies in Advanced NSCLC?
Podcast: GRACEcast
Episode:

Dr. Greg Riely: How Should We Approach Acquired Resistance to Targeted Therapies in Advanced NSCLC?
Category: Science & Medicine
Duration: 00:07:24
Publish Date: 2013-02-23 23:33:24
Description:

Dr. Greg Riely from Memorial Sloan-Kettering reviews strategies for managing acquired resistance to EGFR inhibitors and other targeted therapies in advanced non-small cell lung cancer.
Total Play: 0